Biomerics

Biomerics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Biomerics is a leading, vertically integrated contract development and manufacturing organization (CDMO) for the interventional medical device market. With deep engineering expertise and a full suite of in-house capabilities—from polymer compounding and micro metals processing to design and finished device assembly—the company acts as a strategic partner to global OEMs. Its focus on complex, minimally invasive devices, combined with a global manufacturing footprint including key hubs in Costa Rica and the Dominican Republic, positions it to capitalize on the growing demand for outsourced, innovative medical device manufacturing.

Cardiovascular

Technology Platform

Vertically integrated contract manufacturing platform encompassing in-house polymer compounding, micro metals processing, design services, and finished device assembly for interventional medical devices.

Funding History

1
Total raised:$15M
Series A$15M

Opportunities

The growing trend of OEMs outsourcing complex device manufacturing, coupled with increased demand for minimally invasive surgical tools and robotics, presents a significant growth opportunity.
Biomerics's vertical integration and strategic facilities in Costa Rica offer a compelling value proposition for supply chain resilience and cost-effective scaling.

Risk Factors

Key risks include dependence on the financial health and R&D pipelines of its OEM clients, operational complexities inherent in managing a vertically integrated global manufacturing network, and intense competition in the medical device contract manufacturing sector.

Competitive Landscape

Biomerics competes in the fragmented but competitive medical device contract manufacturing market against large, diversified players like Jabil Healthcare and Flex, as well as specialized niche manufacturers. Its primary competitive differentiation is its deep vertical integration in polymers and metals specifically for the interventional device sector, combined with its strategic nearshoring footprint.